GEHC vs. LLY

Last updated Jun 4, 2026

GEHC (GE HealthCare Technologies Inc.) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — GEHC in Health Information Services, LLY in Drug Manufacturers - General. Over the past 3 years, GEHC returned -7.97%/yr vs 35.56%/yr for LLY. At a 0.24 correlation, their price movements are largely independent.

Performance

GEHC vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GE HealthCare Technologies Inc. (GEHC) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GEHC achieves a -24.31% return, which is significantly lower than LLY's 0.72% return.

GEHC

• 1D: 0.06%
• 1M: 1.69%
• YTD: -24.31%
• 6M: -25.73%
• 1Y: -12.67%
• 3Y*: -7.97%
• 5Y*: —
• 10Y*: —

LLY

• 1D: 1.37%
• 1M: 11.64%
• YTD: 0.72%
• 6M: 4.73%
• 1Y: 44.70%
• 3Y*: 35.56%
• 5Y*: 41.13%
• 10Y*: 32.66%

*Multi-year figures are annualized to reflect compound growth (CAGR)

GEHC vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
GEHC GE HealthCare Technologies Inc.	-24.31%	5.11%	1.26%	27.98%
LLY Eli Lilly and Company	0.72%	40.25%	33.30%	62.12%

Correlation

The correlation between GEHC and LLY is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (All Time) Calculated using the full available price history since Jan 5, 2023	0.24

Fundamentals

Market Cap GEHC : $28.35B LLY : $966.48B
EPS GEHC : $3.29 LLY : $28.14
PE Ratio GEHC : 18.88 LLY : 38.33
PEG Ratio GEHC : 12.07 LLY : 0.77
PS Ratio GEHC : 1.42 LLY : 13.41
PB Ratio GEHC : 2.66 LLY : 30.98
Total Revenue (TTM) GEHC : $19.95B LLY : $72.25B
Gross Profit (TTM) GEHC : $8.49B LLY : $59.75B
EBITDA (TTM) GEHC : $3.16B LLY : $32.97B

Return for Risk

GEHC vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GEHC

GEHC Risk / Return Rank: 23
GEHC Sharpe Ratio Rank: 23
GEHC Sortino Ratio Rank: 23
GEHC Omega Ratio Rank: 22
GEHC Calmar Ratio Rank: 27
GEHC Martin Ratio Rank: 20

LLY

LLY Risk / Return Rank: 72
LLY Sharpe Ratio Rank: 75
LLY Sortino Ratio Rank: 70
LLY Omega Ratio Rank: 71
LLY Calmar Ratio Rank: 73
LLY Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GEHC vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GE HealthCare Technologies Inc. (GEHC) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GEHC	LLY	Difference
Sharpe ratio Return per unit of total volatility	-0.40	1.19	-1.58
Sortino ratio Return per unit of downside risk	-0.34	1.75	-2.09
Omega ratio Gain probability vs. loss probability	0.95	1.24	-0.28
Calmar ratio Return relative to maximum drawdown	-0.39	1.90	-2.29
Martin ratio Return relative to average drawdown	-1.00	4.73	-5.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GEHC vs. LLY - Sharpe Ratio Comparison

The current GEHC Sharpe Ratio is -0.40, which is lower than the LLY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of GEHC and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GEHC	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.40	1.19	-1.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.26	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.09	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.03	0.57	-0.55

Drawdowns

GEHC vs. LLY - Drawdown Comparison

The maximum GEHC drawdown since its inception was -37.35%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for GEHC and LLY.

Drawdown Indicators

	GEHC	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-37.35%	-68.24%	+30.89%
Max Drawdown (1Y) Largest decline over 1 year	-32.47%	-23.64%	-8.83%
Max Drawdown (3Y) Largest decline over 3 years	-37.35%	-34.48%	-2.87%
Max Drawdown (5Y) Largest decline over 5 years	—	-34.48%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	-33.70%	-4.26%	-29.44%
Average Drawdown Average peak-to-trough decline	-14.26%	-19.22%	+4.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.64%	9.49%	+3.15%

Volatility

GEHC vs. LLY - Volatility Comparison

The current volatility for GE HealthCare Technologies Inc. (GEHC) is 7.84%, while Eli Lilly and Company (LLY) has a volatility of 9.16%. This indicates that GEHC experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GEHC	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.84%	9.16%	-1.32%
Volatility (6M) Calculated over the trailing 6-month period	25.67%	26.81%	-1.14%
Volatility (1Y) Calculated over the trailing 1-year period	31.96%	37.88%	-5.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.37%	32.79%	-0.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.37%	30.14%	+2.23%

Dividends

GEHC vs. LLY - Dividend Comparison

GEHC's dividend yield for the trailing twelve months is around 0.23%, less than LLY's 0.60% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GEHC GE HealthCare Technologies Inc.	0.23%	0.17%	0.15%	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.60%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Financials

GEHC vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between GE HealthCare Technologies Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

GEHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GE HealthCare Technologies Inc. reported a gross profit of 1.98B and revenue of 5.13B. Therefore, the gross margin over that period was 38.5%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

GEHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GE HealthCare Technologies Inc. reported an operating income of 515.00M and revenue of 5.13B, resulting in an operating margin of 10.0%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

GEHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GE HealthCare Technologies Inc. reported a net income of 389.00M and revenue of 5.13B, resulting in a net margin of 7.6%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

Frequently Asked Questions

Can I hold both GEHC and LLY in my portfolio?

GEHC and LLY have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, GEHC or LLY?

LLY has higher volatility (9.16%) compared to GEHC (7.84%). In terms of maximum drawdown, GEHC dropped -37.35% vs LLY's -68.24%.

Which has better risk-adjusted returns?

LLY currently has the higher Sharpe Ratio (1.19 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.